Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

2020188 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Ophthalmology

Volume 127, Issue 9, pp. 1201-1210

Field-Weighted Citation Impact: 15.41